RIVM launches study on long-term effectiveness of COVID-19 vaccines RIVM is launching an extensive study today to research the long-term effectiveness of the various COVID-19 vaccines in the Netherlands.
Third wave shows major surge in hospital admissions in younger age groups In the week of 28 April to 4 May, there were 8% fewer new hospital admissions of people with COVID-19 compared to the week before.
First people with medical risk invited for vaccination People with a medical condition who are eligible for an annual seasonal flu vaccination will be invited for a COVID-19 vaccination in phases, starting on Thursday, 6 May.
People born in 1962 invited for COVID-19 vaccination The first people born in 1962 will be receiving an invitation for a COVID-19 vaccination this week. This group involves people who will be turning 59 this year.
Air quality improved, not everywhere below limit values In recent years there has been a decline in the average concentrations of fine particulates and nitrogen dioxide.
Measures EU cities against effects of climate change Some European cities have developed effective policies to adapt to more frequent wet and dry periods forecast for the years ahead, as a result of climate change.
Further research into hazards posed by e-cigarettes Safety of nicotine-containing electronic cigarettes (e-cigarettes) cannot be confirmed because of the limited amount of published research in this area.
End to Marburg risk On 11 July 2008, a Dutch woman died of Marburg haemorrhagic fever, a serious illness caused by the Marburg virus, which she had contracted in Uganda during a visit to a bat cave.